12.07.2015 Views

Protocol de abordare a durerii toracice in urgenta - Cursul national ...

Protocol de abordare a durerii toracice in urgenta - Cursul national ...

Protocol de abordare a durerii toracice in urgenta - Cursul national ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

604tratament <strong>in</strong> faza <strong>de</strong> prespital al <strong>in</strong>farctului miocardic acut cu supra<strong>de</strong>nivelare<strong>de</strong> segment ST - ghid creat pr<strong>in</strong> consensul a sase societati medicale d<strong>in</strong>Romania (4).27. Daca pacientul cu durere toracica are modificari electrocardiograficeale segmentului ST si un<strong>de</strong>i T, altele <strong>de</strong>cat supra<strong>de</strong>nivelarea segmentului ST<strong>de</strong>cizia medicului <strong>de</strong> <strong>urgenta</strong> va fi luata <strong>in</strong> functie <strong>de</strong> valoarea enzimelorcardiace, <strong>in</strong> primul rand al tropon<strong>in</strong>ei I sau T.28.29. Tropon<strong>in</strong>ele sunt cei mai buni markeri biochimici pentru apreciereaprognosticului pe termen scurt (la 30 zile) în ceea ce priveste riscul <strong>de</strong> <strong>in</strong>farctmiocardic si <strong>de</strong>ces. Cresterea riscului asociata cu niveluri crescute aletropon<strong>in</strong>elor este <strong>in</strong><strong>de</strong>pen<strong>de</strong>nta si aditiva celorlalti factori <strong>de</strong> risc precummodificările ECG <strong>in</strong> repaus sau la monitorizarea cont<strong>in</strong>ua sau markeri aiactivitatii <strong>in</strong>flamatorii. In plus, i<strong>de</strong>ntificarea pacientilor cu niveluri crescuteal tropon<strong>in</strong>elor este <strong>de</strong> asemenea utila pentru selectia terapiei a<strong>de</strong>cvate lapacientii cu s<strong>in</strong>droame coronariene acute fara supra<strong>de</strong>nivelare <strong>de</strong> segmentST (9). Un s<strong>in</strong>gur test negativ al tropon<strong>in</strong>ei <strong>in</strong> momentul prezentarii la spitaleste <strong>in</strong>suficient pentru a exclu<strong>de</strong> o crestere ulterioara, <strong>in</strong> conditiile <strong>in</strong> carela cei mai multi pacienti cresterea poate fi <strong>de</strong>tectata <strong>in</strong> orele care urmeaza.Astfel, sunt necesare probe sangv<strong>in</strong>e si masuratori repetate 6-12 ore <strong>de</strong> la<strong>in</strong>ternare si dupa episoa<strong>de</strong>le ang<strong>in</strong>oase severe, cu scopul <strong>de</strong> a <strong>de</strong>monstra saua exclu<strong>de</strong> lezarea miocardica. O a doua <strong>de</strong>term<strong>in</strong>are poate fi necesara doar<strong>in</strong> cazul <strong>in</strong> care ultimul episod ang<strong>in</strong>os a fost prezent la mai mult <strong>de</strong> 12 oreanterior <strong>de</strong>term<strong>in</strong>arii <strong>in</strong>itiale a tropon<strong>in</strong>elor. Este important <strong>de</strong> subl<strong>in</strong>iat casi alte conditii patologice amen<strong>in</strong>tatoare <strong>de</strong> viata, care se prez<strong>in</strong>ta cl<strong>in</strong>ic cudurere toracica, precum disectia anevrismelor aortice sau embolismul pulmonarpot <strong>de</strong>term<strong>in</strong>a cresterea nivelului tropon<strong>in</strong>elor si trebuie <strong>in</strong>tot<strong>de</strong>aunaavute <strong>in</strong> ve<strong>de</strong>re ca diagnostice diferentiale. Cresteri ale tropon<strong>in</strong>elor cardiaceapar <strong>de</strong> asemenea <strong>in</strong> cadrul leziunilor miocardice non-coronariene (tabelnr. 3).Evaluarea riscului <strong>de</strong> catre echipa medicala d<strong>in</strong> <strong>urgenta</strong> are rolul <strong>de</strong> a impartipacientii cu durere <strong>toracice</strong> <strong>de</strong> tip ischemic, fara supra<strong>de</strong>nivelare <strong>de</strong> ST<strong>in</strong> trei grupe: risc crescut, risc <strong>in</strong>termediar si risc scazut.Urmatorii predictori ai <strong>de</strong>cesului pe termen lung sau a aparitiei <strong>in</strong>farctuluimiocardic trebuie luati <strong>in</strong> consi<strong>de</strong>rare <strong>in</strong> stratificarea riscului (Clasa I,Nivel B) (9):- <strong>in</strong>dicatori cl<strong>in</strong>ici: varsta, frecventa cardiaca, tensiunea arteriala, clasaKillip, diabet, boala cardiaca ischemica sau <strong>in</strong>farct miocardic <strong>in</strong> antece<strong>de</strong>nte;- markeri ECG: sub<strong>de</strong>nivelare <strong>de</strong> segment ST;- markeri <strong>de</strong> laborator: tropon<strong>in</strong>e, BNP/NT-proBNP, hsCRP;Recomandări şi Protocoale în Anestezie, Terapie Intensivă şi Medic<strong>in</strong>ă <strong>de</strong> Urgenţă

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!